ENO2 and neoplasm: Some traditional tumor markers have been applied in screening, occurrence and prognosis prediction for LSCC33, including squamous cell carcinoma antigen (SCC), carcino-embryonic antigen (CEA), cytokeratins21-2 and neuron specific enolase (NSE).